Control Bionics GridPad Trilogy image

Control Bionics has announced the newest addition to its augmentative and alternative communication (AAC) device line: the GridPad Trilogy™ multi-modal communication solution.

The new neuro-based voice output communication aid is intended to help people with a range of conditions, including ALS, Spinal Muscular Atrophy (SMA), cerebral palsy and Spinal Cord Injury, find their voice.

Offering touch control, eye control, and NeuroNode™ 3.0 control within the same system, the GridPad Trilogy is a unique 3-in-1 AAC device that progresses and grows with clients and their abilities. It allows for faster communication, at rates up to 133 percent compared to other systems, says Control Bionics.

Additionally, the new AAC solution offers multiple access methods within the same system, meaning the traditional limits on access methods and features are alleviated, making it accessible to those who need it most.

“Our mission is to develop accessible, leading-edge AAC devices that can help those living with paralysis and loss of speech gain more control over their world,” said Rob Wong, CEO of Control Bionics. “Our latest solution, the GridPad Trilogy, is the result of strategic partnerships with some of the best minds in the industry, resulting in a technology that provides unparalleled benefits for our clients.”

The GridPad Trilogy features Control Bionics wireless wearable NeuroNode 3.0 technology combined with the powerful Smartbox Grid Pad 12 computer system and IntelliGaze™ v5 eye gaze device from Alea Technologies.

Smartbox creates assistive technology to help children and adults with disabilities communicate and live more independently. Designed in collaboration with AAC users, Grid Pad features an all-day battery life and multiple access options.

Alea Technologies melds human and machine vision capabilities to provide user-friendly, fully integrated products for wide-spread use. The IntelliGaze systems help physically challenged users to communicate with relatives and their environment by embodying the latest advances in machine vision in an easy-to-use computer input device.

Control Bionics says this innovative combination of technologies allows for faster typing speed, less user fatigue and more control. GridPad Trilogy also boasts 12-hour battery life for added reliability and flexibility.

Control Bionics Trilogy image

“The new GridPad Trilogy will be an integral part of our product line, further enhancing our augmentative communication device offering,” added James Schorey, Chief Technology Officer at Control Bionics. “While our current Trilogy solution will continue to offer clients portability and speed, the new GridPad Trilogy is a more robust solution with unmatched battery life, sound quality and durability, rounding out our line to appeal to all needs.”

The GridPad Trilogy AAC device is powered by an Intel Core i5 processor, 8GB of RAM, GRID3 software, and a solid -state hard drive, enabling quick, seamless communication. Furthermore, with enhanced sound and volume, and a hardened glass, 12.5” touchscreen display, this new solution offers added quality and durability.

Founded in 2006 to create a reliable switch for users that found all other solutions ineffective, fatiguing and limiting to their needs, Control Bionics has established its presence in the world of AAC devices.

Over 7,000 healthcare professionals stay informed about the latest assistive technology with AT Today. Do you?
We respect your privacy